SCICLONE PHARMACEUTICALS

SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. It has a product portfolio of therapies for cancer and infectious diseases. SciClone has in-licensed two products that are part of this international commercial growth strategy, DC Bead and ondansetron RapidFilm. Its DC Bead product candidate is a treatment for liver cancer, which is approved in 40 countries worldwide, including Europe and the United States. Ondansetron RapidFilm is an oral thin film formula... tion of ondansetron used to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy and surgery. SCV-07 is being developed for the delay of onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck and for the treatment of hepatitis C virus (HCV). Thymalfasin is being developed in an ongoing clinical trial for improvement of Influenza A (H1N1) vaccination.
SCICLONE PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1990-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.sciclone.com
Total Employee:
501+
Status:
Active
Contact:
(650) 358-3456
Email Addresses:
[email protected]
Total Funding:
134 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro AJAX Libraries API ASP.NET IIS Sectigo SSL Sectigo Domain SSL ASP.NET 4.0
Similar Organizations
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
ZWI Therapeutics, Inc.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2011-04-19 | NovaMed Pharmaceuticals | NovaMed Pharmaceuticals acquired by SciClone Pharmaceuticals | 105 M USD |
Investors List
Opportunity Fund
Opportunity Fund investment in Venture Round - SciClone Pharmaceuticals
Shanghai Pharmaceutical
Shanghai Pharmaceutical investment in Venture Round - SciClone Pharmaceuticals
IDG Capital
IDG Capital investment in Venture Round - SciClone Pharmaceuticals
Grand View Capital
Grand View Capital investment in Venture Round - SciClone Pharmaceuticals
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-12-28 | Ability Pharmaceuticals | SciClone Pharmaceuticals investment in Corporate Round - Ability Pharmaceuticals | 3 M USD |
Official Site Inspections
http://www.sciclone.com Semrush global rank: 3.38 M Semrush visits lastest month: 4.65 K
- Host name: 113-28-176-121.static.imsbiz.com
- IP address: 113.28.176.121
- Location: Central Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong

More informations about "SciClone Pharmaceuticals"
SciClone Pharmaceuticals
Feb 25, 2025 SciClone Pharmaceuticals was founded in 1998 in San Francisco, California by an entrepreneurial group of medical, business, and research professionals. In 2004, the company โฆSee details»
SciClone Pharmaceuticals (Holdings) Limited
SciClone is a global biopharmaceutical company with an integrated platform for the development and commercialization of innovative therapies for cancer and severe infection.See details»
SciClone Pharmaceuticals - Crunchbase Company โฆ
SciClone Pharmaceuticals, Inc. (SciClone ) is a global specialty pharmaceutical company. It has a product portfolio of therapies for cancer and infectious โฆSee details»
SciClone Pharmaceuticals Inc - Org Chart, Teams, Culture & Jobs
View SciClone Pharmaceuticals Inc's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Sciclone Pharmaceuticals Org Chart + Executive Team
The org chart of Sciclone Pharmaceuticals contains its 15 main executives including Hong Zhao and Rongrong Pan.See details»
sciclone.com WHOIS Domain Name Lookup - who.is
Sep 8, 1997 Find information on any domain name or website. Large database of whois information, RDAP, DNS, domain names, name servers, IPs, and tools for searching and โฆSee details»
SciClone Pharmaceuticals Holdings Ltd - Company Profile and News
May 13, 2020 SciClone Pharmaceuticals (Holdings) Limited operates as a biopharmaceutical company. The Company develops, produces and sells oncology drug, infectious diseases โฆSee details»
SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED
May 31, 2020 SciClone Pharmaceuticals (Holdings) Ltd is a company principally engaged in the provision of treatment plans for tumors and severe infectious diseases. The Company and its โฆSee details»
SciClone Pharmaceuticals Information - RocketReach
SciClone Pharmaceuticals is a Pharmaceuticals, Pharmaceutical Manufacturing, and Drug Manufacturing & Research company located in Foster City, California with $433.5 million in โฆSee details»
SciClone Pharmaceuticals - Overview, News & Similar companies ...
Feb 12, 2019 View SciClone Pharmaceuticals (www.sciclone.com) location in Shanghai, China , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
SciClone Pharmaceuticals Company Profile | Management and
Find contact information for SciClone Pharmaceuticals. Learn about their Drug Stores & Pharmacies, Retail market share, competitors, and SciClone Pharmaceuticals's email format.See details»
SciClone Pharmaceuticals - 2025 Company Profile & Team - Tracxn
Jul 14, 2025 SciClone Pharmaceuticals is a public company based in Shanghai (China), founded in 1989. It operates as a Specialty biopharma company that develops and commercializes โฆSee details»
SciClone Pharmaceuticals (Holdings) Ltd. - Drug pipelines, Patents ...
Aug 7, 2023 Explore SciClone Pharmaceuticals (Holdings) Ltd. with its drug pipeline, therapeutic area, technology platform, 27 clinical trials, 24 news, and 3 literature, Disease โฆSee details»
SciClone Pharmaceuticals Holdings - Cbonds.com
SciClone Pharmaceuticals (Holdings) Limited operates as a biopharmaceutical company. The Company develops, produces and sells oncology drug, infectious diseases drugs, and other โฆSee details»
SciClone Pharmaceuticals, Inc. - VentureRadar
"SciClone Pharmaceuticals (Holdings) Limited is a biopharmaceutical company focused on the development and commercialization of innovative therapies. The company's portfolio includes โฆSee details»
SciClone Pharmaceuticals (Holdings) (SCCPF) Company Profile, โฆ
SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. The company is headquartered โฆSee details»
SciClone Pharmaceuticals 2025 Company Profile: Valuation, โฆ
Information on valuation, funding, acquisitions, investors, and executives for SciClone Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
SciClone Pharmaceuticals, Inc.: Shareholders Board Members โฆ
SciClone Pharmaceuticals, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»
SciClone Pharmaceuticals Company Profile - Office Locations ...
SciClone Pharmaceuticals has 5 employees at their 1 location and $160.1 m in annual revenue in FY 2016. See insights on SciClone Pharmaceuticals including office locations, competitors, โฆSee details»
่ต็่ฏไธๆง่กๆ้ๅ ฌๅธ SciClone Pharmaceuticals (Holdings) Limited
SciClone Pharmaceuticals (Holdings) Limited (โSciClone Pharmaceuticalsโ, HKEX:6600) is a global biopharmaceutical company with an integrated platform for the development and โฆSee details»